HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Kuroda Selected Research

Edaravone

7/2016Edaravone Reduces Hyperperfusion-Related Neurological Deficits in Adult Moyamoya Disease: Historical Control Study.
12/2008Edaravone (MCI-186) scavenges reactive oxygen species and ameliorates tissue damage in the murine spinal cord injury model.
12/2004Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Kuroda Research Topics

Disease

22Moyamoya Disease (Moya-Moya Disease)
10/2023 - 12/2004
21Ischemic Stroke
03/2024 - 12/2008
17Stroke (Strokes)
03/2024 - 10/2002
16Hemorrhage
03/2024 - 01/2013
15Infarction (Infarctions)
03/2024 - 03/2004
15Carotid Stenosis (Carotid Artery Stenosis)
02/2024 - 02/2005
15Ischemia
03/2015 - 01/2003
14Aneurysm (Aneurysms)
09/2020 - 01/2005
14Cerebral Infarction
01/2017 - 09/2003
13Brain Infarction
01/2017 - 03/2004
8Neoplasms (Cancer)
12/2023 - 11/2006
8Brain Ischemia (Cerebral Ischemia)
10/2023 - 03/2004
8Pathologic Constriction (Stenosis)
10/2020 - 01/2005
7Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018 - 09/2003
6Carotid Artery Diseases
01/2017 - 06/2004
6Spinal Cord Injuries (Spinal Cord Injury)
05/2014 - 09/2003
4Hematoma
11/2023 - 09/2008
4Cysts
01/2023 - 10/2016
4Parkinson Disease (Parkinson's Disease)
10/2021 - 01/2014
4Hypertension (High Blood Pressure)
01/2021 - 06/2012
4Glioma (Gliomas)
03/2019 - 09/2011
4Cognitive Dysfunction
01/2017 - 10/2007
4Nervous System Diseases (Neurological Disorders)
01/2013 - 08/2004
4Central Nervous System Diseases (CNS Diseases)
06/2011 - 04/2010
3Prostatic Neoplasms (Prostate Cancer)
10/2023 - 01/2021
3Thrombosis (Thrombus)
01/2022 - 01/2011
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
09/2020 - 03/2015
3Rupture
09/2020 - 09/2006
3Lacunar Stroke
10/2019 - 01/2013
3Glioblastoma (Glioblastoma Multiforme)
03/2019 - 01/2015
3Brain Neoplasms (Brain Tumor)
08/2018 - 11/2006
3Inflammation (Inflammations)
12/2017 - 06/2010
3Traumatic Brain Injuries (Traumatic Brain Injury)
04/2012 - 04/2010
3Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
06/2011 - 11/2004
3Ruptured Aneurysm
03/2010 - 09/2006
2Adenoma (Adenomas)
12/2023 - 08/2022
2Hydrocephalus (Hydrocephaly)
01/2023 - 01/2022
2Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 08/2018
2COVID-19
01/2021 - 12/2020
2Paresis (Hemiparesis)
10/2020 - 01/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2019 - 02/2005
2Disease Progression
02/2019 - 01/2018
2Transient Ischemic Attack
01/2018 - 09/2007
2Arteriovenous Malformations (Arteriovenous Malformation)
01/2014 - 11/2004
2Intracranial Aneurysm (Cerebral Aneurysm)
01/2011 - 03/2005
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2010 - 02/2008

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2004
7Therapeutic UsesIBA
10/2020 - 04/2010
7Oxygen (Dioxygen)IBA
09/2014 - 12/2003
6Acetazolamide (Diamox)FDA LinkGeneric
11/2013 - 12/2003
5LipidsIBA
01/2021 - 01/2013
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2016 - 05/2009
5Neuroprotective AgentsIBA
03/2016 - 03/2004
4Biomarkers (Surrogate Marker)IBA
10/2023 - 04/2018
4Protein Kinases (Protein Kinase)IBA
03/2019 - 01/2018
4Glucose (Dextrose)FDA LinkGeneric
01/2013 - 09/2009
3Phenobarbital (Luminal)FDA Link
10/2020 - 02/2019
3N-acetyltalosaminuronic acid (NAT)IBA
01/2018 - 10/2014
3Alprostadil (Muse)FDA LinkGeneric
01/2018 - 01/2015
3EdaravoneIBA
07/2016 - 12/2004
3Free Radical ScavengersIBA
07/2016 - 12/2004
3triphenyltetrazoliumIBA
01/2005 - 03/2004
2ferric oxide (iron oxide)IBA
03/2024 - 09/2011
2Keratins (Keratin)IBA
08/2022 - 10/2016
2Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 01/2013
2Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2013
23-Iodobenzylguanidine (Iobenguane)IBA
10/2021 - 01/2016
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2019 - 01/2011
2OTS964IBA
03/2019 - 01/2018
2Temozolomide (Temodar)FDA LinkGeneric
03/2019 - 01/2015
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2018 - 12/2016
2Green Fluorescent ProteinsIBA
01/2018 - 01/2013
2Polyglycolic Acid (Polyglycolide)IBA
05/2017 - 03/2005
2Fibrin Tissue Adhesive (Fibrin Sealant)IBA
05/2017 - 03/2005
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2017 - 09/2014
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2013 - 01/2011
2Bovine Serum AlbuminIBA
09/2011 - 06/2011
2Aligeron (AS 2)IBA
08/2009 - 05/2009
2Superoxides (Superoxide)IBA
12/2008 - 12/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008 - 12/2004

Therapy/Procedure

31Therapeutics
03/2024 - 07/2004
26Transplantation
03/2024 - 09/2003
15Carotid Endarterectomy
02/2024 - 01/2005
11Craniotomy
03/2024 - 05/2004
6Cell Transplantation
01/2018 - 10/2007
6Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018 - 01/2010
5Operative Surgical Procedures
01/2021 - 09/2006
5Ligation
07/2017 - 01/2005
4Radiotherapy
10/2023 - 10/2002
4Stents
03/2016 - 02/2005
4Deep Brain Stimulation
01/2016 - 01/2014
3Aftercare (After-Treatment)
11/2022 - 08/2012
3Drug Therapy (Chemotherapy)
01/2022 - 02/2011
3Transcranial Direct Current Stimulation
10/2021 - 01/2018
2Perioperative Period
09/2020 - 08/2014
2Sutures (Suture)
05/2017 - 11/2006
2Decompression
03/2015 - 01/2012
2Endovascular Procedures
11/2011 - 04/2004
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2010 - 02/2008
2Cerebral Revascularization
01/2010 - 11/2008